Abstract
Large conductance, Ca2+-activated potassium (BK) channels play important roles in the regulation of neuronal excitability and the control of smooth muscle contractions. BK channels can be activated by changes in both the membrane potential and intracellular Ca2+ concentrations. Here, we provide an overview of the structural and pharmacological properties of BK channel blockers. First, the properties of different venom peptide toxins from scorpions and snakes are described, with a focus on their characteristic structural motifs, including their disulfide bond formation pattern, the binding interface between the toxin and BK channel, and the functional consequence of the blockage of BK channels by these toxins. Then, some representative non-peptide blockers of BK channels are also described, including their molecular formula and pharmacological effects on BK channels. The detailed categorization and descriptions of these BK channel blockers will provide mechanistic insights into the blockade of BK channels. The structures of peptide toxins and non-peptide compounds could provide templates for the design of new channel blockers, and facilitate the optimization of lead compounds for further therapeutic applications in neurological disorders or cardiovascular diseases.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wang ZW . Regulation of synaptic transmission by presynaptic CaMKII and BK channels. Mol Neurobiol 2008; 38: 153–66.
Wu RS, Marx SO . The BK potassium channel in the vascular smooth muscle and kidney: alpha- and beta-subunits. Kidney Int 2010; 78: 963–74.
Wang X, Inukai T, Greer MA, Greer SE . Evidence that Ca2+-activated K+ channels participate in the regulation of pituitary prolactin secretion. Brain Res 1994; 662: 83–7.
Marty A . Ca-dependent K channels with large unitary conductance in chromaffin cell membranes. Nature 1981; 291: 497–500.
Wiecha J, Munz B, Wu Y, Noll T, Tillmanns H, Waldecker B . Blockade of Ca2+-activated K+ channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J Vasc Res 1998; 35: 363–71.
Weaver AK, Liu X, Sontheimer H . Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 2004; 78: 224–34.
Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ, et al. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 2007; 26: 2525–34.
Salkoff L, Butler A, Ferreira G, Santi C, Wei A . High-conductance potassium channels of the SLO family. Nat Rev Neurosci 2006; 7: 921–31.
Contreras GF, Castillo K, Enrique N, Carrasquel-Ursulaez W, Castillo JP, Milesi V, et al. A BK (Slo1) channel journey from molecule to physiology. Channels (Austin) 2013; 7: 442–58.
Meera P, Wallner M, Song M, Toro L . Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. Proc Natl Acad Sci U S A 1997; 94: 14066–71.
Wallner M, Meera P, Toro L . Determinant for beta-subunit regulation in high-conductance voltage-activated and Ca2+-sensitive K+ channels: an additional transmembrane region at the N terminus. Proc Natl Acad Sci U S A 1996; 93: 14922–7.
Koval OM, Fan Y, Rothberg BS . A role for the S0 transmembrane segment in voltage-dependent gating of BK channels. J Gen Physiol 2007; 129: 209–20.
Liu HW, Hou PP, Guo XY, Zhao ZW, Hu B, Li X, et al. Structural basis for calcium and magnesium regulation of a large conductance calcium-activated potassium channel with beta1 subunits. J Biol Chem 2014; 289: 16914–23.
Dopico AM, Bukiya AN . Lipid regulation of BK channel function. Front Physiol 2014; 5: 312.
Shi J, Krishnamoorthy G, Yang Y, Hu L, Chaturvedi N, Harilal D, et al. Mechanism of magnesium activation of calcium-activated potassium channels. Nature 2002; 418: 876–80.
Cui J, Yang H, Lee US . Molecular mechanisms of BK channel activation. Cell Mol Life Sci 2009; 66: 852–75.
Latorre R, Morera FJ, Zaelzer C . Allosteric interactions and the modular nature of the voltage- and Ca2+-activated (BK) channel. J Physiol 2010; 588: 3141–8.
Tomas M, Vazquez E, Fernandez-Fernandez JM, Subirana I, Plata C, Heras M, et al. Genetic variation in the KCNMA1 potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction. J Hypertens 2008; 26: 2147–53.
Seibold MA, Wang B, Eng C, Kumar G, Beckman KB, Sen S, et al. An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet 2008; 17: 2681–90.
McGahon MK, Zhang X, Scholfield CN, Curtis TM, McGeown JG . Selective downregulation of the BKbeta1 subunit in diabetic arteriolar myocytes. Channels (Austin) 2007; 1: 141–3.
Du W, Bautista JF, Yang H, Diez-Sampedro A, You SA, Wang L, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet 2005; 37: 733–8.
Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA, Couraud PO, et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer 2009; 9: 258.
Miller C, Moczydlowski E, Latorre R, Phillips M . Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature 1985; 313: 316–8.
Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, et al. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 1990; 265: 11083–90.
Candia S, Garcia ML, Latorre R . Mode of action of iberiotoxin, a potent blocker of the large conductance Ca2+-activated K+ channel. Biophys J 1992; 63: 583–90.
Novick J, Leonard RJ, King VF, Schmalhofer W, Kaczorowski GJ . Purification and characterization of two novel peptidyl toxins directed against K channels from venom of new world scorpions. Biophys J 1991.
Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin-Eauclaire MF, van der Walt JJ, et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol Sci 1999; 20: 444–7.
MacKinnon R, Miller C . Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J Gen Physiol 1988; 91: 335–49.
Lucchesi K, Ravindran A, Young H, Moczydlowski E . Analysis of the blocking activity of charybdotoxin homologs and iodinated derivatives against Ca2+-activated K+ channels. J Membr Biol 1989; 109: 269–81.
Renisio JG, Lu Z, Blanc E, Jin W, Lewis JH, Bornet O, et al. Solution structure of potassium channel-inhibiting scorpion toxin Lq2. Proteins 1999; 34: 417–26.
Miller C . Competition for block of a Ca2+-activated K+ channel by charybdotoxin and tetraethylammonium. Neuron 1988; 1: 1003–6.
Bontems F, Roumestand C, Boyot P, Gilquin B, Doljansky Y, Menez A, et al. Three-dimensional structure of natural charybdotoxin in aqueous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins. Eur J Biochem 1991; 196: 19–28.
MacKinnon R, Latorre R, Miller C . Role of surface electrostatics in the operation of a high-conductance Ca2+-activated K+ channel. Biochemistry 1989; 28: 8092–9.
MacKinnon R, Miller C . Functional modification of a Ca2+-activated K+ channel by trimethyloxonium. Biochemistry 1989; 28: 8087–92.
Park CS, Miller C . Mapping function to structure in a channel-blocking peptide: electrostatic mutants of charybdotoxin. Biochemistry 1992; 31: 7749–55.
Stampe P, Kolmakova-Partensky L, Miller C . Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin. Biochemistry 1994; 33: 443–50.
Park CS, Miller C . Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel. Neuron 1992; 9: 307–13.
Hermann A, Erxleben C . Charybdotoxin selectively blocks small Ca-activated K channels in Aplysia neurons. J Gen Physiol 1987; 90: 27–47.
Attali B, Romey G, Honore E, Schmid-Alliana A, Mattei MG, Lesage F, et al. Cloning, functional expression, and regulation of two K+ channels in human T lymphocytes. J Biol Chem 1992; 267: 8650–7.
MacKinnon R, Reinhart PH, White MM . Charybdotoxin block of Shaker K+ channels suggests that different types of K+ channels share common structural features. Neuron 1988; 1: 997–1001.
Banerjee A, Lee A, Campbell E, Mackinnon R . Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K+ channel. Elife 2013; 2: e00594.
Neusch C, Weishaupt JH, Bahr M . Kir channels in the CNS: emerging new roles and implications for neurological diseases. Cell Tissue Res 2003; 311: 131–8.
Johnson BA, Sugg EE . Determination of the three-dimensional structure of iberiotoxin in solution by 1H nuclear magnetic resonance spectroscopy [Comparative Study]. Biochemistry 1992; 31: 8151–9.
Ferrat G, Bernard C, Fremont V, Mullmann TJ, Giangiacomo KM, Darbon H . Structural basis for alpha-K toxin specificity for K+ channels revealed through the solution 1H NMR structures of two noxiustoxin-iberiotoxin chimeras. Biochemistry 2001; 40: 10998–1006.
Zheng YM, Park SW, Stokes L, Tang Q, Xiao JH, Wang YX . Distinct activity of BK channel beta1-subunit in cerebral and pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 2013; 304: C780–9.
Zhang J, Halm ST, Halm DR . Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon. Am J Physiol Gastrointest Liver Physiol 2012; 303: G1322–34.
Blanc E, Romi-Lebrun R, Bornet O, Nakajima T, Darbon H . Solution structure of two new toxins from the venom of the Chinese scorpion Buthus martensi Karsch blockers of potassium channels. Biochemistry 1998; 37: 12412–8.
Romi-Lebrun R, Lebrun B, Martin-Eauclaire MF, Ishiguro M, Escoubas P, Wu FQ, et al. Purification, characterization, and synthesis of three novel toxins from the Chinese scorpion Buthus martensi, which act on K+ channels. Biochemistry 1997; 36: 13473–82.
Harvey AL, Vatanpour H, Rowan EG, Pinkasfeld S, Vita C, Menez A, et al. Structure-activity studies on scorpion toxins that block potassium channels. Toxicon 1995; 33: 425–36.
Marshall DL, Vatanpour H, Harvey AL, Boyot P, Pinkasfeld S, Doljansky Y, et al. Neuromuscular effects of some potassium channel blocking toxins from the venom of the scorpion Leiurus quinquestriatus hebreus. Toxicon 1994; 32: 1433–43.
Garcia-Valdes J, Zamudio FZ, Toro L, Possani LD . Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes. FEBS Lett 2001; 505: 369–73.
Crest M, Jacquet G, Gola M, Zerrouk H, Benslimane A, Rochat H, et al. Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca2+-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom. J Biol Chem 1992; 267: 1640–7.
Korukottu J, Schneider R, Vijayan V, Lange A, Pongs O, Becker S, et al. High-resolution 3D structure determination of kaliotoxin by solid-state NMR spectroscopy. PLoS One 2008; 3: e2359.
Pentelute BL, Mandal K, Gates ZP, Sawaya MR, Yeates TO, Kent SB . Total chemical synthesis and X-ray structure of kaliotoxin by racemic protein crystallography. Chem Commun (Camb) 2010; 46: 8174–6.
Fernandez I, Romi R, Szendeffy S, Martin-Eauclaire MF, Rochat H, Van Rietschoten J, et al. Kaliotoxin (1-37) shows structural differences with related potassium channel blockers. Biochemistry 1994; 33: 14256–63.
Aiyar J, Withka JM, Rizzi JP, Singleton DH, Andrews GC, Lin W, et al. Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins. Neuron 1995; 15: 1169–81.
Laraba-Djebari F, Legros C, Crest M, Ceard B, Romi R, Mansuelle P, et al. The kaliotoxin family enlarged. Purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom. J Biol Chem 1994; 269: 32835–43.
Wang Y, Chen X, Zhang N, Wu G, Wu H . The solution structure of BmTx3B, a member of the scorpion toxin subfamily alpha-KTx 16. Proteins 2005; 58: 489–97.
Tao J, Zhou ZL, Wu B, Shi J, Chen XM, Ji YH . Recombinant expression and functional characterization of martentoxin: a selective inhibitor for BK channel (alpha + beta4). Toxins (Basel) 2014; 6: 1419–33.
Shi J, He HQ, Zhao R, Duan YH, Chen J, Chen Y, et al. Inhibition of martentoxin on neuronal BK channel subtype (alpha+beta4): implications for a novel interaction model. Biophys J 2008; 94: 3706–13.
Tao J, Shi J, Yan L, Chen Y, Duan YH, Ye P, et al. Enhancement effects of martentoxin on glioma BK channel and BK channel (alpha+beta1) subtypes. PLoS One 2011; 6: e 15896.
Cai Z, Xu C, Xu Y, Lu W, Chi CW, Shi Y, et al. Solution structure of BmBKTx1, a new BKCa1 channel blocker from the Chinese scorpion Buthus martensi Karsch. Biochemistry 2004; 43: 3764–71.
Xu CQ, Brone B, Wicher D, Bozkurt O, Lu WY, Huys I, et al. BmBKTx1, a novel Ca2+-activated K+ channel blocker purified from the Asian scorpion Buthus martensi Karsch. J Biol Chem 2004; 279: 34562–9.
Holaday SK Jr, Martin BM, Fletcher PL Jr, Krishna NR . NMR solution structure of butantoxin. Arch Biochem Biophys 2000; 379: 18–27.
M'Barek S, Chagot B, Andreotti N, Visan V, Mansuelle P, Grissmer S, et al. Increasing the molecular contacts between maurotoxin and Kv1.2 channel augments ligand affinity. Proteins 2005; 60: 401–11.
Novello JC, Arantes EC, Varanda WA, Oliveira B, Giglio JR, Marangoni S . TsTX-IV, a short chain four-disulfide-bridged neurotoxin from Tityus serrulatus venom which acts on Ca2+-activated K+ channels. Toxicon 1999; 37: 651–60.
Yao J, Chen X, Li H, Zhou Y, Yao L, Wu G, et al. BmP09, a “long chain” scorpion peptide blocker of BK channels. J Biol Chem 2005; 280: 14819–28.
Wang J, Shen B, Guo M, Lou X, Duan Y, Cheng XP, et al. Blocking effect and crystal structure of natrin toxin, a cysteine-rich secretory protein from Naja atra venom that targets the BKCa channel. Biochemistry 2005; 44: 10145–52.
Tu X, Wang J, Guo M, Zheng D, Teng M, Niu L, et al. Purification, partial characterization, crystallization and preliminary X-ray diffraction of two cysteine-rich secretory proteins from Naja atra and Trimeresurus stejnegeri venoms. Acta Crystallogr D Biol Crystallogr 2004; 60: 1108–11.
Garcia ML, Hanner M, Knaus HG, Slaughter R, Kaczorowski GJ . Scorpion toxins as tools for studying potassium channels. Methods Enzymol 1999; 294: 624–39.
Park CS, Hausdorff SF, Miller C . Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels. Proc Natl Acad Sci U S A 1991; 88: 2046–50.
Bende NS, Dziemborowicz S, Mobli M, Herzig V, Gilchrist J, Wagner J, et al. A distinct sodium channel voltage-sensor locus determines insect selectivity of the spider toxin Dc1a. Nat Commun 2014; 5: 4350.
Schilling S, Wasternack C, Demuth HU . Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution. Biol Chem 2008; 389: 983–91.
Kaczorowski GJ, Knaus HG, Leonard RJ, McManus OB, Garcia ML . High-conductance calcium-activated potassium channels; structure, pharmacology, and function. J Bioenerg Biomembr 1996; 28: 255–67.
Nardi A, Calderone V, Chericoni S, Morelli I . Natural modulators of large-conductance calcium-activated potassium channels. Planta Med 2003; 69: 885–92.
John E, Starrett J, Steven I, Dworetzky, Valentin K, Gribkoff . Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Current Pharmaceeutical Design 1996; 2: 413–28.
Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, et al. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 1994; 33: 5819–28.
Cole RJ, Cox RH . Handbook of Toxic Fungal Metabolites. 1981: 355–509.
Norris PJ, Smith CC, De Belleroche J, Bradford HF, Mantle PG, Thomas AJ, et al. Actions of tremorgenic fungal toxins on neurotransmitter release. J Neurochem 1980; 34: 33–42.
Villarroel A, Alvarez O, Oberhauser A, Latorre R . Probing a Ca2+-activated K+ channel with quaternary ammonium ions. Pflugers Arch 1988; 413: 118–26.
Harper AA, Catacuzzeno L, Trequattrini C, Petris A, Franciolini F . Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes. J Membr Biol 2001; 179: 103–11.
Wickenden A . K+ channels as therapeutic drug targets. Pharmacol Ther 2002; 94: 157–82.
Marcie G, Berger NJR . Voltage and calcium-gated potassium channels: Functional expression and therapeutic potential in the vasculature. Perspectives in Drug Discovery and Design 1999; 15-16: 313–32.
Wang G, Lemos JR . Tetrandrine blocks a slow, large-conductance, Ca2+-activated potassium channel besides inhibiting a non-inactivating Ca2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch 1992; 421: 558–65.
Wu SN, Li HF, Lo YC . Characterization of tetrandrine-induced inhibition of large-conductance calcium-activated potassium channels in a human endothelial cell line (HUV-EC-C). J Pharmacol Exp Ther 2000; 292: 188–95.
Wu SN, Li HF, Jan CR, Shen AY . Inhibition of Ca2+-activated K+ current by clotrimazole in rat anterior pituitary GH3 cells. Neuropharmacology 1999; 38: 979–89.
Chiang HT, Wu SN . Inhibition of large-conductance calcium-activated potassium channel by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells. J Membr Biol 2001; 182: 203–12.
Liu YC, Lo YC, Huang CW, Wu SN . Inhibitory action of ICI-182,780, an estrogen receptor antagonist, on BKCa channel activity in cultured endothelial cells of human coronary artery. Biochem Pharmacol 2003; 66: 2053–63.
Zhou Y, Lingle CJ . Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism. J Gen Physiol 2014; 144: 415–40.
Anderson CS, MacKinnon R, Smith C, Miller C . Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength. J Gen Physiol 1988; 91: 317–33.
Giangiacomo KM, Garcia ML, McManus OB . Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 1992; 31: 6719–27.
Schroeder N, Mullmann TJ, Schmalhofer WA, Gao YD, Garcia ML, Giangiacomo KM . Glycine 30 in iberiotoxin is a critical determinant of its specificity for maxi-K versus KV channels. FEBS Lett 2002; 527: 298–302.
Gao YD, Garcia ML . Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels. Proteins 2003; 52: 146–54.
Hu H, Shao LR, Chavoshy S, Gu N, Trieb M, Behrens R, et al. Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci 2001; 21: 9585–97.
Tricarico D, Capriulo R, Camerino DC . Involvement of KCa 2+ channels in the local abnormalities and hyperkalemia following the ischemia-reperfusion injury of rat skeletal muscle. Neuromuscul Disord 2002; 12: 258–65.
Ge L, Hoa NT, Wilson Z, Arismendi-Morillo G, Kong XT, Tajhya RB, et al. Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. Int Immunopharmacol 2014; 22: 427–43.
Olesen SP, Munch E, Moldt P, Drejer J . Selective activation of Ca2+-dependent K+ channels by novel benzimidazolone. Eur J Pharmacol 1994; 251: 53–9.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (31100847), Youth Innovation Promotion Association CAS (2012323), the Fundamental Research Funds for the Central Universities of China (WK2070000033) to Long-hua ZHANG, and Specialized Research Fund for the Doctoral Program of Higher Education (20113402110058) to Chang-lin TIAN.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yu, M., Liu, Sl., Sun, Pb. et al. Peptide toxins and small-molecule blockers of BK channels. Acta Pharmacol Sin 37, 56–66 (2016). https://doi.org/10.1038/aps.2015.139
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2015.139
Keywords
This article is cited by
-
Magmatic systems beneath Ashikule volcanic cluster (Western Kunlun, China): insights from compositional and textural features of lavas
Arabian Journal of Geosciences (2020)
-
Microbial production of toxins from the scorpion venom: properties and applications
Applied Microbiology and Biotechnology (2018)
-
A novel BK channel-targeted peptide suppresses sound evoked activity in the mouse inferior colliculus
Scientific Reports (2017)
-
Ion channels research in the post-genomic era
Acta Pharmacologica Sinica (2016)
